Mitochondriln GST pedstavuj tdu kappa a mikrozomln GST se dl do ty podskupin I-IV
Bonekamp N
wherein H251 is substituted with either an A, C, D, E, F, G, I, K, L, M, N, P, Q, R, S, T, V, W, or Y
Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update
ATEKLWVTVY;TEKLWVTVYY;KLWVTVYYGV;WVTVYYGVPV;VTV YYGVPVW;TVYYGVPVWK;VPVWKEATTT;PVWKEATTTL;VWKEA TTTLFiTTTLFCASDAiTTLFCASDAKjTLFCASDAKAjLFCASDAKAY ;KAYDTEVHNV;AYDTEVHNVW;EVHNVW ATHA;HNVW ATHACV;P TDPNPQEVV;DPNPQEVVLV;NPQEVVLVNV;VVLVNVTENF;NVTE NFNMWK;NMWKNDMVEQ;EQMHEDIISL;DIISLWDQSL;IISLWDQS LK;SLWDQSLKPC;KLTPLCVSLK;CVSLKCTDLK;DTNTNSSSGR;N TNSSSGRMIiSSSGRMIMEKiRMIMEKGEIKiGEIKNCSFNIiNCSFNI STSIiCSFNISTSIRjNISTSIRGKViSTSIRGKVQKiSIRGKVQKEYjRG KVQKEYAFiKVQKEYAFFYiVQKEYAFFYKjEYAFFYKLDIjFFYKLDII PlilPIDNDTTSYiYKLTSCNTSVjKLTSCNTSVIjTSVITQACPKiSVITQ ACPKVilTQACPKVSFjVSFEPIPIHYjEPIPIHYCAPilPIHYCAPAGiH YCAPAGFAIjYCAPAGFAILiCAPAGFAILKiFAILKCNNKTjAILKCNN KTFjTGPCTNVSTViSTVQCTHGIRiVQCTHGIRPViGIRPVVSTQLjR PVVSTQLLL;STQLLLNGSL;TQLLLNGSLA;LLLNGSLAEE;LNGSLA EEEViSLAEEEVVIRiAEEEVVIRSViEEVVIRSVNFiEVVIRSVNFTiR SVNFTDNAKiFTDNAKTIIViTIIVQLNTSViNTSVEINCTRiCTRPNNN TRKiRPNNNTRKRIiNTRKRIRIQRiRIRIQRGPGRiRIQRGPGRAFiIQ RGPGRAFViPGRAFVTIGKiFVTIGKIGNMiVTIGKIGNMRiMRQAHC NISRiRQAHCN ISRAiQAHCNISRAKiSRAKWNNTLKiNTLKQIASKL
